Johnson & Johnson vs KeyCorp — how do they compare? Johnson & Johnson trades at $250.66 (market cap $598.96B), while KeyCorp trades at $23.55 (market cap $25.17B). The key difference: Johnson & Johnson is far larger — about 23.8× KeyCorp's market cap, and KeyCorp pays the higher dividend (3.52%). Which is the better fit depends on your goals.
| JNJ | KEY | |
|---|---|---|
Market Cap | $598.96B | $25.17B |
Volume | 6,156,228 | — |
Sector | Health | Financials |
52-Week High | $267.24 | $23.99 |
52-Week Low | $164.36 | $16.78 |
Enterprise Value | $631.90B | — |
Dividend Yield | 2.15% | 3.52% |
Trailing returns across standard periods
Latest headlines on both assets
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →With assets of over $170 billion, Ohio-based KeyCorp's bank footprint spans 16 states, but it is predominantly concentrated in its two largest markets: Ohio and New York. KeyCorp is primarily focused on serving middle-market commercial clients through a hybrid community/corporate bank model.
Read more on KEY →